Meeting
2023 ASCO Annual Meeting
Identification of cytokines associated with response and cytokine release syndrome: Analysis of MagnetisMM-3 cohort A.
Authors
HANG QUACH
St. Vincent’s Hospital, University of Melbourne, Melbourne, VIC, Australia
HANG QUACH , Nizar J. Bahlis , Paula Rodríguez-Otero , Andrea Viqueira , Shen-Wu Wang , Sangeetha Sathaiah , Douglas M Robinson , Thomas O'Brien , Katja Weisel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies
Sub Track
Multiple Myeloma
Clinical Trial Registration Number
NCT04649359
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 8044)
DOI
10.1200/JCO.2023.41.16_suppl.8044
Abstract #
8044
Poster Bd #
36
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Dynamics of circulating cytokines and chemokines during and after tumor-infiltrating lymphocyte cell therapy with lifileucel in advanced melanoma patients.
First Author: Rongsu Qi
Poster
2019 ASCO Annual Meeting
A donor-dependent in vivo model for single agent and drug combination cytokine release syndrome safety evaluation.
First Author: James G. Keck
Poster
2022 ASCO Annual Meeting
Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC).
First Author: Giulia Pasello
Poster
2021 Genitourinary Cancers Symposium
A phase I clinical trial of PSMA-directed/TGFβ-insensitive CAR-T cells in metastatic castration-resistant prostate cancer.
First Author: Vivek Narayan